ASPAVELI 1080 mg, solution for infusion bottle, 20 ml
Active ingredients: PEGCÉTACOPLAN
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusionbottle, 20 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ASPAVELI 1080 mg, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- SWEDISH ORPHAN BIOVITRUM (SUEDE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 May 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67568483CIP73024365CIP133400930243657Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PEGCÉTACOPLANsolution | 1080 mg · un flacon de 20 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.